Publication | Closed Access

Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study

AsthmaAllergyPersonalised Reduction AlgorithmAllergy MedicineImmunologyOral ImmunotherapyOral Corticosteroid EliminationPharmacotherapyEosinophilic AsthmaEosinophilic DisorderImmunotherapyMedicine